Cardiol Therapeutics's total assets for Q2 2025 were C$19.94M, a decrease of -21.67% from the previous quarter. TSE:CRDL total liabilities were C$8.13M for the fiscal quarter, a 3.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.